motor hyperactivity in chronic nicotine-treated rats (striatum). Eur
J Pharmacol 152:263–271.
Gentry CL, Lukas RJ (2002) Regulation of nicotinic acetylcholine receptor
numbers and function by chronic nicotine exposure. Curr Drug Targets
CNS Neurol Disord 1:359 –385.
Grady SR, Salminen O, Laverty DC, Whiteaker P, McIntosh JM, Collins AC,
Marks MJ (2007) The subtypes of nicotinic acetylcholine receptors on
dopaminergic terminals of mouse striatum. Biochem Pharmacol
74:1235–1246.
Green AR, Hainsworth AH, Jackson DM (2000) GABA potentiation: a logical pharmacological approach for the treatment of acute ischaemic
stroke. Neuropharmacology 39:1483–1494.
Hadj Tahar A, Gre ́ goire L, Darre ́ A, Be ́ langer N, Meltzer L, Be ́ dard PJ (2004)
Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias
in drug-naive parkinsonian monkeys. Neurobiol Dis 15:171–176.
Harkness PC, Millar NS (2002) Changes in conformation and subcellular
distribution of 4 2 nicotinic acetylcholine receptors revealed by chronic
nicotine treatment and expression of subunit chimeras. J Neurosci
22:10172–10181.
Jiang ZG, North RA (1991) Membrane properties and synaptic responses of
rat striatal neurones in vitro. J Physiol 443:533–553.
Kaiser S, Wonnacott S (2000) -bungarotoxin-sensitive nicotinic receptors
indirectly modulate [ 3H]dopamine release in rat striatal slices via glutamate release. Mol Pharmacol 58:312–318.
Klink R, de Kerchove d'Exaerde A, Zoli M, Changeux JP (2001) Molecular
and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 21:1452–1463.
Koo ́ s T, Tepper JM (1999) Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat Neurosci 2:467– 472.
Koutsilieri E, Riederer P (2007) Excitotoxicity and new antiglutamatergic
strategies in Parkinson's disease and Alzheimer's disease. Parkinsonism
Relat Disord 13 [Suppl 3]:S329 –S331.
Kuryatov A, Luo J, Cooper J, Lindstrom J (2005) Nicotine acts as a pharmacological chaperone to up-regulate human 4 2 acetylcholine receptors.
Mol Pharmacol 68:1839 –1851.
Lacey MG, Mercuri NB, North RA (1989) Two cell types in rat substantia
nigra zona compacta distinguished by membrane properties and the ac- tions of dopamine and opioids. J Neurosci 9:1233–1241.
Lester HA, Xiao C, Srinivasan R, Son CD, Miwa J, Pantoja R, Banghart MR,
Dougherty DA, Goate AM, Wang JC (2009) Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. AAPS J 11:167–177.
Lo ́ pez-Herna ́ ndez GY, Sa ́ nchez-Padilla J, Ortiz-Acevedo A, Lizardi-Ortiz J,
Salas-Vincenty J, Rojas LV, Lasalde-Dominicci JA (2004) Nicotineinduced up-regulation and desensitization of 4 2 neuronal nicotinic
receptors depend on subunit ratio. J Biol Chem 279:38007–38015.
Mansvelder HD, Keath JR, McGehee DS (2002) Synaptic mechanisms un- derlie nicotine-induced excitability of brain reward areas. Neuron
33:905–919.
Marchi M, Risso F, Viola C, Cavazzani P, Raiteri M (2002) Direct evidence
that release-stimulating 7* nicotinic cholinergic receptors are localized
on human and rat brain glutamatergic axon terminals. J Neurochem
80:1071–1078.
Marks MJ, Stitzel JA, Collins AC (1986) Dose-response analysis of nicotine
tolerance and receptor changes in two inbred mouse strains. J Pharmacol
Exp Ther 239:358 –364.
Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, Heinemann SF,
Collins AC (1992) Nicotine binding and nicotinic receptor subunit RNA
after chronic nicotine treatment. J Neurosci 12:2765–2784.
Marks MJ, Rowell PP, Cao JZ, Grady SR, McCallum SE, Collins AC (2004)
Subsets of acetylcholine-stimulated 86[Rb] efflux and 125[I]-epibatidine
binding sites in C57BL/6 mouse brain are differentially affected by chronic
nicotine treatment. Neuropharmacology 46:1141–1157.
Marshall DL, Redfern PH, Wonnacott S (1997) Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in
vivo microdialysis: comparison of naive and chronic nicotine-treated rats.
J Neurochem 68:1511–1519.
McCallum SE, Parameswaran N, Bordia T, Fan H, McIntosh JM, Quik M
(2006a) Differential regulation of mesolimbic 3*/ 6* 2 and 4* 2
nicotinic acetylcholine receptor sites and function after long-term oral
nicotine to monkeys. J Pharmacol Exp Ther 318:381–388.
McCallum SE, Parameswaran N, Bordia T, Fan H, Tyndale RF, Langston JW,
